Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Karyopharm Therapeutics Inc. buy Robert W. Baird

Karyopharm Therapeutics Inc.
Start price
€0.54
13.05.25 / 50%
Target price
€37.81
13.05.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 13.05.26. The prediction end date can be changed by Robert_W__Baird at any time.
Performance without dividends (%)
Name 1w 1m
Karyopharm Therapeutics Inc. - -
iShares Core DAX® -0.099% 0.273%
iShares Nasdaq 100 -1.085% 1.502%
iShares Nikkei 225® -0.835% 3.273%
iShares S&P 500 0.099% 1.988%

Comments by Robert_W__Baird for this prediction

In the thread Karyopharm Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 37.813
Change
Ends at 13.05.26

Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target lowered by analysts at Robert W. Baird from $54.00 to $42.00. They now have an "outperform" rating on the stock.
Ratings data for KPTI provided by MarketBeat

Robert W. Baird 
0
Report Share
13.05.25

Stopped prediction by Robert_W__Baird for Karyopharm Therapeutics Inc.

buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.54
12.08.25
€21.52
12.08.26
-
25.02.25

Robert W. Baird 
12.08.25 50%
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.54
03.03.25
€51.55
03.03.26
-
25.02.25

Robert W. Baird 
03.03.25 50%
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.72
07.08.24
€4.57
07.08.25
-25.10%
08.08.25

Robert W. Baird 
07.08.24 50%